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Edited by Gianni CesareniAbstract Loop ﬂexibility is discussed as a factor that aﬀects li-
gand binding aﬃnity of SH3 domains. To test this hypothesis, we
designed a mutant in which a proline in the RT-loop of the hu-
man Lck SH3-domain is replaced by glycine. The dynamics
and ligand binding properties of wild-type and mutant LckSH3
were studied by ﬂuorescence and NMR spectroscopy as well as
molecular dynamics simulations. Although the mutated residue
does not form direct contacts with the ligand, the mutation in-
creases ligand aﬃnity by a factor of eight. The mutant exhibits
increased loop ﬂexibility and enhanced sampling of binding-com-
petent conformations. This eﬀect is expected to facilitate ligand
binding itself and might also allow formation of tighter contacts
in the complex thus resulting in an increased binding aﬃnity.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The Src homology 3 (SH3) domain is one of the most com-
monly found modular protein domain in eukaryotic genomes
and more than 2700 SH3 domains have been identiﬁed so
far. SH3 domains are relatively short (60–70 residues) noncat-
alytic protein modules [1] whose primary activity is to bind
proline-rich ligands containing a consensus sequence xP–x–
xP motif that forms a canonical type II polyproline helix [2].
For most SH3 domains the ligand-binding site consists of
two hydrophobic slots, each occupied by a xP dipeptide, and
a third, negatively charged speciﬁcity pocket that accommo-
dates an adjacent basic residue of the ligand [2,3]. Thus, upon
binding only ﬁve core ligand residues contact the SH3 domain
of which two are invariant prolines and one is a basic residue,
leaving little space for speciﬁcity. It was recently shown that
additional contacts between variable surface patches of the
SH3 domain and ligand residues N-terminal or C-terminal to
the core can greatly enhance aﬃnity and speciﬁcity [4–10].
Short peptides which cover only the proline-rich sequence
stretch without ﬂanking residues, however, can also diﬀer in
their binding speciﬁcity – even for closely related SH3 do-*Corresponding author. Fax: +49 9131 8522485.
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doi:10.1016/j.febslet.2007.03.012mains. For example, the aﬃnities of a short peptide derived
from the herpesviral Tip-protein for the SH3 domains of sev-
eral Src-family kinases (Lck, Hck, Lyn, Src, Fyn, Yes) diﬀer
by almost one order of magnitude, and the highest aﬃnities
are found for Lck, Hck and Lyn [11]. Similar diﬀerences in
the binding behaviour have also been noted for the HIV-Nef
protein and have been attributed to diﬀerences in the ﬂexibility
of the RT-loop that forms a part of the ligand binding site [12].
Residues R18 and T19 of the RT-loop, which are conserved in
Fyn, Src, and Yes form tight intramolecular hydrogen bonds
resulting in a stiﬀ loop in FynSH3. In contrast, two substitu-
tions (R18I, T19H) in HckSH3 preclude the hydrogen bonding
network from forming. The resulting increased ﬂexibility of the
RT-loop was suggested to enhance ligand binding by facilitat-
ing the adoption of a binding-competent conformation. In
Lck, the substitutions R18S and T19H were suggested to result
in a highly ﬂexible RT loop as observed in Hck; however, the
presence of P17 is likely to signiﬁcantly reduce the mobility in
this region [12].
In order to address the question whether the binding aﬃnity
of LckSH3 can be enhanced by increasing the ﬂexibility of the
RT-loop, we designed a mutant in which P17 of the RT-loop is
replaced by glycine. The dynamics and ligand binding proper-
ties of wild-type and mutant LckSH3 were studied by ﬂuores-
cence and NMR spectroscopy as well as molecular dynamics
simulations. Our study reveals a signiﬁcantly increased ligand
binding aﬃnity of the mutant which correlates with a slightly
increased ﬂexibility of the RT-loop and an enhanced sampling
of ligand binding-competent conformations.2. Materials and methods
2.1. Cloning, expression, and puriﬁcation of LckSH3(P17G)
Nucleotides comprising the SH3 domain of Lck(P17G) were cloned
via PCR from the clone of wild-type LckSH3 [11] into the BamHI and
EcoRI restriction sites of pGEX-4T-1 (Amersham Bioscience) using
the oligonucleotides LckSH3_P17G_5 0 (GGA GGA GGA TCC
CCA CTG CAA GAC AAC ATG GTT ATC GCT CTG CAC
AGC TAT GAG GGG TCT CAC GAC GGA GAT CTG GGC)
and LckSH3_30 (GGA GGA GAA TTC AGT TCG CTT TGG
CCA CAA AAT TGA AGG GG) (MWG-Biotech, Ebersberg, Ger-
many). The numbering scheme used throughout this paper will refer
to the expressed protein, in which P17 corresponds to P74 of full-
length Lck. The vector pGEX-LckSH3(P17G) provides an N-terminal
glutathion S-transferase (GST) aﬃnity tag cleavable with thrombin.
Expression and puriﬁcation of LckSH3(P17G) were performed as de-
scribed previously for wild-type LckSH3 [11], which has the following
sequence (P17 shown in bold): 1GSPLQDNLVI ALHSYEPSHD
GDLGFEKGEQ LRILEQSGEW WKAQSLTTGQ EGFIPFNFVA
KAN63. For 15N labelling M9 minimal medium was used with [15N]-
ammonium chloride as the sole nitrogen source.blished by Elsevier B.V. All rights reserved.
Fig. 1. Fluorescence binding studies of Tip(168–187) to wild-type
LckSH3 (triangles) and LckSH3(P17G) (squares). The ﬂuorescence
signal was detected at 340 nm after excitation at 280 nm. All intensities
were normalized to a maximum value of 1. Curves were ﬁtted
according to the equation given in Section 2, and give aﬃnities of
16.80 ± 0.61 lM for LckSH3 and 2.23 ± 0.26 lM for LckSH3(P17G).
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For ﬂuorescence studies, a synthetic peptide comprising residues
A168–G187 of Tip (sequence: 168ATLDPGMPTPPLPPRPANLG187)
was purchased from Coring (Gernsheim, Germany). Although the pro-
line-rich core motif of Tip was shown to be suﬃcient for aﬃne Lck
binding, the longer peptide was used to keep consistent with previous
studies [8]. For undisturbed detection of SH3 ﬂuorescence upon addi-
tion of ligand, W170 was replaced by leucine which had been shown
previously to have no eﬀect on the binding aﬃnity [11]. In addition,
the N- and C-terminus of the peptides were acetylated and amidated,
respectively, to adjust the propensities in the peptide to those of the in-
tact protein [13]. For the NMR titration experiment recombinantly ex-
pressed Tip(140–191) was used, that was expressed and puriﬁed as
described in Bauer et al. [14].
2.3. Fluorescence spectroscopy and calculation of binding constants
All ﬂuorescence spectra were measured in a F-4500 ﬂuorescence
spectrophotometer (Hitachi, Tokyo, Japan) at an excitation wave-
length of 280 nm and an emission wavelength of 340 nm at 291 K. A
semi-micro quartz ﬂuorescence cell (light path 10 · 4 mm) with mag-
netic stirrer was used. Stock solutions of up to 5 mM of synthesized
Tip(168–187) were added in small increments to 700 ll of 0.5 lM
SH3 domain in 50 mM Tris/HCl, 150 mM NaCl, pH 7.4, and subse-
quently stirred for 2 min. Afterwards, the ﬂuorescence was recorded
for 30 s and averaged. Since the concentration of the SH3 domain
was low compared to the ligand, the experimental data were ﬁtted to
the standard equation
DF ¼ DF max  ½peptide
KD þ ½peptide
where [peptide] gives the ﬁnal ligand concentration at each measure-
ment point, F is the measured protein ﬂuorescence intensity at the par-
ticular peptide concentration, and Fmax is the observed maximal
ﬂuorescence intensity of the protein when saturated with the peptide.
Nonlinear regression curve ﬁtting was carried out to ﬁt the experimen-
tal data to the equation, with Fmax and KD as ﬁtted parameters. The
change in protein concentration that occurred as a result of peptide
addition was properly corrected.
2.4. NMR spectroscopy
NMR experiments were recorded on a Bruker 600 MHz spectrome-
ter (Bruker, Karlsruhe, Germany) equipped with pulsed ﬁeld gradients
capabilities at 298 K. NMR samples contained 1.2 mM 15N-labeled
LckSH3 in 40 mM potassium phosphate and 20 mM sodium chloride,
pH 6.4, in H2O/D2O (9:1). The {
1H}15N–NOE experiments were re-
corded using the pulse sequences of Dayie and Wagner [15]. The relax-
ation delay was 4 s, and the proton saturation was performed by 120
high-power pulses with an interpulse delay of 5 ms for the ﬁnal 3 s of
the relaxation delay of the saturation experiment.
2.5. MD simulations
Six independent MD simulations using diﬀerent starting structures
were performed for wild-type and mutant LckSH3. The six templates
for the wild-type simulation were taken from the set of NMR struc-
tures (PDB code: 1H92; [11]). For the simulations of the mutant,
P17 was replaced by glycine in each of the wild-type templates.
All molecular dynamics (MD) simulations were performed using the
AMBER 7 program [16] with the parm99 force ﬁeld [17,18] and the
TIP3P water model [19] in a periodic water box with at least 10 A˚ of
solvent around every atom of the solute. An appropriate number of
counter ions was added to neutralize the charges of the systems, and
the Particle Mesh Ewald summation method [20] was employed to cal-
culate the long-range electrostatic interactions. MD simulations were
performed using the SHAKE procedure [21] to constrain all bonds
involving hydrogen atoms. The integration time step of the simulation
was 1.5 fs, and a 9.0 A˚ cutoﬀ was used for the nonbonded interactions.
All systems were minimized and equilibrated prior to MD production.
First the positions of the solvent atoms were optimized using a steepest
descent algorithm, while the solute was restrained by a harmonic func-
tion with a force constant of 500 kcal mol1 A˚2. Subsequently, the
temperature of the system was risen from 50 K to 300 K during
18.75 ps of MD. In the next 18.75 ps, the system was simulated at
300 K and electrostatic interactions were now explicitly included. In
the last stage of the preparation phase 37.5 ps MD were simulated inwhich the harmonic restraints on the solute were gradually removed.
Subsequently, 1-ns MD simulations were performed for data collection
and structures were saved every 1.5 ps for further analysis. For the
visualization and structural analysis of the data, the programs MolMol
[22], VMD [23], AMBER [16], and X-PLOR [24] were used.3. Results and discussion
3.1. Ligand binding aﬃnity
The aﬃnity of wild-type and mutant LckSH3 for the pro-
line-rich ligand Tip(168–187) was determined using ﬂuores-
cence spectroscopy. These experiments revealed that
replacement of P17 by glycine actually increases the aﬃnity
by almost one order of magnitude from 16.8 lM to 2.2 lM
(Fig. 1).
Additional insight into the mode of LckSH3(P17G)–Tip
interaction was obtained from a NMR titration experiment
using 15N-labeled LckSH3(P17G) (Fig. 2). The HSQC-spec-
trum of LckSH3(P17G) and the magnitude of the chemical
shift changes upon Tip addition are highly similar to those
of the wild-type system [11]. This ﬁnding conﬁrms that the
overall mode of interaction is not altered by the mutation. Like
for the wild-type complex, however, fast and intermediate ex-
change on the NMR timescale (Fig. 2) impeded the determina-
tion of a high resolution complex structure.
Information about the location of the mutation with respect
to the ligand binding site was therefore obtained from a NMR-
based model of the Tip–Lck complex [14] and from the high-
resolution three-dimensional structure of the homologous
LynSH3–Tip complex [8]. Both complex structures reveal that
residues H13, Y15, D22, W40, F53, and P55–F58 of LckSH3
form direct contacts with the ligand. In contrast, residue 17
is located in approximately 5 A˚ distance to the ligand binding
site (Fig. 3), and does not form any van der Waals contacts
with the ligand. Thus, the increase in aﬃnity in LckSH3(P17G)
must be achieved by an indirect mechanism supporting our
hypothesis that this mutation might increase the ﬂexibility of
the RT-loop and facilitate the formation of a binding-compe-
tent conformation.
Fig. 2. NMR titration experiment showing the changes in the 1H, 15N HSQC spectrum of free LckSH3(P17G) (red) upon gradual addition of
Tip(140–191). Resonances belonging to the spectrum after the ﬁnal step of titration (ﬁvefold molar excess of Tip) are shown in green. Resonances are
labelled with the corresponding sequence positions. Start and end point of resonances with intermediate exchange behaviour on the NMR timescale
are connected (solid lines). Side-chain NH2 resonances for glutamine and asparagine are connected (dashed lines).
Fig. 3. Ligand binding region of LckSH3. (A) NMR-based model of the LckSH3–Tip complex (from [14]). LckSH3 is shown in space-ﬁlled
presentation and all atoms which are closer than 5 A˚ to the ligand are coloured in red. Residues 176–187 of Tip, that are involved in LckSH3 binding,
are shown as blue sticks. (B) Schematic presentation of the Tip–LckSH3 complex (same view as in (A)). The site of mutation is marked by an arrow
and the three major loops are labelled. Red lines connect the Ca-carbons of residues closer than 5 A˚ to the ligand that were used to deﬁne the binding-
competent conformation.
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The overall dynamics on a ps–ns timescale was investigated
by NMR spectroscopy and molecular dynamics (MD) simula-
tions. Measurement of the {1H}15N heteronuclear NOE showsthat the overall dynamics of LckSH3 is not aﬀected by the
mutation (Fig. 4A). In particular, the dynamics of the second-
ary structure elements (Fig. 4A; grey bars) is virtually identi-
cal in both proteins and is close to the theoretically expected
Fig. 4. Dynamics of wild-type LckSH3 (open circles) and
LckSH3(P17G) (ﬁlled circles) as deduced from NMR spectroscopy
and MD simulations. (A) Magnitude of the {1H} 15N heteronuclear
NOE at a nitrogen resonance frequency of 60.8 MHz. Error bars
indicate the diﬀerence in peak intensity between two reference spectra
before and after the experiment. (B) Magnitude of the atomic
ﬂuctuations of the backbone atoms (Ca, C 0, NH) in LckSH3. Error
bars indicate the mean standard deviation over six MD simulations.
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600 MHz [25].
The replacement of proline by glycine, however, causes a lo-
cally increased protein dynamics as indicated by the lower val-
ues of the heteronuclear NOE. The eﬀect is particular evident
for the residues C-terminally adjacent to the site of the muta-
tion, which form the tip of the RT-loop. This region contains
several residues that interact directly with the ligand – in par-
ticular D22 forms an essential salt-bridge to R182 of Tip [8,14].
This local increase in ﬂexibility in the mutant is also reﬂected inFig. 5. Portion of binding-competent conformations in LckSH3 (left) and Lc
Ca-distances that deﬁne the binding-competent conformation were within a gi
a total of 4002 conformations (667 from each of the six independent MD s
competent conformation was sampled approximately two times more frequen
at 0.5 A˚ tolerance).the MD simulations and larger atomic ﬂuctuations are ob-
served in the RT-loop (residues L12–F29) and distal loop (res-
idues L50–G53) (Fig. 4B). The distal loop forms contacts with
the RT-loop (Fig. 3B) explaining why its dynamics is also af-
fected by the presence of the mutation.
Generally, the loop ﬂexibility is only moderately increased in
the mutant on the ps–ns timescale but this eﬀect might become
more pronounced on ls–ms timescales which are not yet acces-
sible by conventional MD techniques. One should, however,
also take into account that a highly ﬂexible mutant would
experience a large loss of conformational entropy upon ligand
binding which would counteract a high binding aﬃnity. There-
fore, high aﬃnity mutants are not necessarily expected to be
highly ﬂexible. A point, which is more important than the ﬂex-
ibility itself, is the structure of the conformations sampled by
the free SH3 domain, since the portion of binding-competent
conformations is expected to aﬀect complex association and
thereby ligand aﬃnity.
3.3. Conformational sampling of wild-type and mutant Lck
According to our original hypothesis, we tested whether
the P17G mutation facilitates ligand binding by increasing
the portion of binding-competent conformations. For that
purpose we deﬁned the binding-competent conformation of
LckSH3 based on the model of the Tip–LckSH3 complex
(Fig. 3B; [14]). All residues of LckSH3 which have at least
one atom in a distance of less than 5 A˚ from the ligand were
considered relevant to maintain the binding-competent con-
formation. This criterion applies to residues H13–E16, S18,
H19, D22, S37–W41, F53, and P55–F58, thus including
those residues directly involved in Tip binding (see above)
and some of their adjacent residues. The pairwise distances
between the Ca-atoms of the respective residues (136 in
total) were used to deﬁne the geometry of the binding-
competent conformation.
Subsequently, the LckSH3 conformations sampled during
MD simulation were screened for their consistency with these
Ca-distances. A total of 4002 conformations (667 from each ofkSH3(P17G) (right). A vertical black bar indicates that all 136 pairwise
ven threshold of 1.0 A˚ (A) or 0.5 A˚ (B). The analysis was performed for
imulations). Independent of the tolerance criterion used, the binding-
t in the mutant (379 vs. 174 times at 1.0 A˚ tolerance and 42 vs. 21 times
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LckSH3 and LckSH3(P17G), respectively (Fig. 5). A structure
was considered as binding-competent, if all 136 pairwise Ca-
distances deviated less than 1.0 A˚ (Fig. 5A) or less than
0.5 A˚ (Fig. 5B) from those distances observed in the Tip-
LckSH3 complex structure. Independent of the tolerance crite-
rion used, the binding-competent conformation was sampled
approximately two times more frequent in the mutant (379
vs. 174 times at 1.0 A˚ tolerance and 42 vs. 21 times at 0.5 A˚ tol-
erance). In order to identify the reasons why the P17G muta-
tion favours the binding competent conformation, the
structure of the Tip–LckSH3 complex was analyzed in detail.
In the complex, the conformation observed for P17 of the
LckSH3 backbone is quite strained (/ = 41; w = 143) for
a proline. As a consequence, the /-angle of P17 changes during
the simulation sampling energetically more favourable values
for the /-angle of approximately 80, while this eﬀect is ob-
served to a much lesser extent for the mutant.
Our data shows that the P17G mutation slightly increases
the local ﬂexibility and alters the conformational sampling in
a way that increases portion of binding-competent conforma-
tions in the free LckSH3 domain. This eﬀect is expected to
facilitate binding itself and might also allow formation of tigh-
ter contacts in the complex thus oﬀering a plausible explana-
tion for the increased binding aﬃnity of the mutant.
The eﬀect of protein dynamics on the ligand binding proper-
ties has been described in the past for numerous systems
including thrombin [26], cAMP-dependent protein kinase
[27], estrogen receptor [28], aldol reductase [29,30], thymidyl-
ate synthase [31], trypsin [32], and HIV-1 protease [33–35].
Mutants in these proteins, which alter the aﬃnity of ligand
binding, frequently aﬀect also protein dynamics. This correla-
tion has been thoroughly investigated by MD simulations for
HIV-1 protease, for which numerous mutations are known
that decrease ligand binding aﬃnity. At least three of these
mutations (E35D, N88S, V82F/I84V) were shown to inﬂuence
the conformational sampling of the free protease: The E35D
and V82F/I84V mutations aﬀect the motions of a loop (‘ﬂap’)
which is part of the ligand binding pocket. This loop preferen-
tially adopts a more open conformation in the mutant protease
[33,35] thereby distorting the shape of the ligand binding
pocket. The N88S mutant alters the hydrogen bonding
pattern, and residue D30, which is important for inhibitor
binding, is ﬁxed in an intramolecular hydrogen bond with
S88, thereby reducing the number of binding-competent
conformations [34]. Thus, apart from their opposite eﬀect on
the ligand aﬃnity itself, these properties of mutant HIV-1
proteases are highly similar to the eﬀect observed for
LckSH3(P17G).
Studies of protein dynamics, however, are not only relevant
for understanding the eﬀects that govern the aﬃnity between
mutant proteins and known ligands, but might also be helpful
for the design of novel ligands that exhibit an increased aﬃnity
or speciﬁcity. Incorporation of protein plasticity in drug design
has already been successfully applied to thymidylate synthase
and lead to several speciﬁc inhibitors that were missed by con-
ventional docking procedures [31].Acknowledgements: This work was supported by a grant from the
Deutsche Forschungsgemeinschaft to H.S. (SFB466, C11). The
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